Aemetis (AMTX) Q1 2026 earnings review
Top-Line Turnaround Marred by Crushing Debt Burden
Aemetis delivered a stable 27% YoY revenue acceleration to $54.6M in Q1 2026, fueled by the resumption of India Biodiesel shipments and a 55% surge in Dairy Renewable Natural Gas (RNG) volumes. The operational story is improving: gross profit reversed from a -$5.1M loss to positive $2.8M YoY, and the company finally recognized its first quarter of ongoing Section 45Z Production Tax Credits ($4.0M). However, below the operating line, the narrative fractures. A staggering $16.0M in total interest expense completely wiped out operational gains, driving a severe -$21.7M net loss. With only $4.8M in cash against $396.2M in current liabilities, the company's survival hinges almost entirely on near-term debt refinancing and the targeted IPO of its India subsidiary.
🐂 Bull Case
After a lumpy Q4 2025 where full-year 45Z credits were recognized retroactively, Q1 2026 successfully demonstrated a normalized quarterly cadence with $4.0M in 45Z credits booked. Combined with 7 approved LCFS pathways yielding a deeply negative -380 CI score, the regulatory margin tailwinds are finally materializing.
Following zero production in Q1 2025 due to OMC tender delays, the India Biodiesel facility resumed operations, generating $10.5M in revenue and providing a crucial growth driver ahead of its planned 2026 IPO.
🐻 Bear Case
The company holds just $4.8M in cash against $293.8M in the current portion of long-term debt. Without a massive refinancing or an immediate equity injection from the India IPO, liquidity is critically compromised.
Despite a 60% YoY improvement in operating loss, Aemetis still lost $21.7M on the bottom line. The $16.0M quarterly interest burden is structurally unsustainable at current cash flow generation levels.
⚖️ Verdict: 🔴
Bearish. While management successfully executed on RNG scaling and tax credit monetization, the extreme imbalance between the $4.8M cash position and $396.2M in current liabilities overshadows the operational turnaround. The fundamental equity story rests on exogenous financing events.
Key Themes
Dairy RNG Volume is Accelerating
The Dairy RNG segment is demonstrating clear, stable execution. Sales volume grew 55% YoY to 110,000 MMBtu. Importantly, revenues now include LCFS credits from 7 approved pathways carrying an average Carbon Intensity (CI) score of negative 380, drastically superior to the negative 150 default score applied in Q1 2025. With six additional pathways nearing approval, this segment's margin profile is set to expand further.
45Z Tax Credits Normalize (Macro Driver)
A massive policy driver for Aemetis has officially transitioned from a promised windfall to recurring revenue. The company recognized $4.0M in Section 45Z Production Tax Credits ($1.4M in RNG, $2.6M in Ethanol) for Q1 2026. Management explicitly stated this represents the first quarter of ongoing credit generation tied directly to quarterly production, removing the 'lumpy' recognition uncertainty that plagued 2025.
Mechanical Vapor Recompression (MVR) Execution
Innovation execution is advancing at the Keyes ethanol plant. The company received the first delivery of major equipment for the $40 million MVR system. Once operational, this technology will use on-site solar and local geothermal grid electricity to displace approximately 80% of fossil natural gas used at the plant, heavily improving the carbon intensity score and driving an estimated $32M in annual cash flow.
Structural Liquidity Crisis
Management's narrative focuses heavily on margin expansion and scaling, but the balance sheet aggressively contradicts this optimism. Cash dipped slightly to $4.8M from $4.9M at the end of 2025. Total current liabilities stand at an alarming $396.2M. While the company outlines a 'multi-track financing plan', execution risk is extremely high, and the sheer weight of short-term obligations threatens the equity value.
Crushing Interest Burden Outpaces Growth
Interest expense (including debt fees and accretion of Series A preferred units) hit $16.0M for the quarter, flat from $16.0M YoY. While operating losses improved by $9.2M YoY, this progress is rendered moot by the cost of capital. Aemetis is essentially borrowing at punitive rates to fund CapEx ($6.5M in Q1), acting as a treadmill where operational improvements cannot catch up to debt servicing costs.
Stagnant Core Ethanol Volumes
While RNG and India segments generated the growth narrative, the legacy California Ethanol segment is decelerating. Ethanol gallons sold dropped slightly to 13.7 million in Q1 2026 from 14.1 million a year ago. The average selling price remained entirely flat at $1.97 per gallon, leaving this segment dependent exclusively on 45Z tax credits to justify its economics.
Other KPIs
Reversing from the positive $1.9M achieved in 24Q4, but a massive acceleration compared to the -$10.7M recorded in Q1 2025. The YoY improvement is driven directly by the positive gross margin flip resulting from LCFS pathway approvals and RNG scale.
Accelerating significantly from $1.8M in Q1 2025. Despite the liquidity crisis, Aemetis continues to aggressively deploy capital toward carbon intensity reductions at the Keyes ethanol plant and the construction of dairy digesters, betting that these yields will enable a refinancing.
Reversing from $0 in Q1 2025. The resumption of OMC tender shipments under new contracts resulted in 9.2k metric tons sold, achieving 24.5% nameplate capacity utilization. This is the cornerstone of the company's pitch for the upcoming Universal Biofuels Private Limited IPO.
Guidance
Management expects LCFS revenues to accelerate significantly in the later quarters of 2026. This relies on the pending approval of 6 additional biogas provisional pathways, which will join the 7 currently approved pathways that hold a -380 CI score.
Management expects to provide an update on investment banking engagement in the near term regarding the initial public offering of its India subsidiary. This event is critical for raising the capital needed to address the parent company's debt burden.
Stable. The company explicitly guided that 45Z accrual and monetization will normalize on a quarterly cadence going forward, ending the lumpy recognition seen throughout 2025. Further upside is expected pending publication of the updated 45ZCF-GREET model by the DOE.
Key Questions
Refinancing the Wall of Debt
With $293.8M in current long-term debt obligations and only $4.8M in cash, what specific mechanisms (e.g., bridge loans, asset sales) are in place to prevent a liquidity event if the India IPO is delayed past 2026?
MVR System Execution Timeline
Major equipment for the Mechanical Vapor Recompression system has been delivered. What is the exact quarter in 2026 when this facility will become fully operational, and how quickly will the projected $32M in annual cash flow be realized?
45ZCF-GREET Model Updates
You noted further improvement to 45Z accruals is pending the updated 45ZCF-GREET model from the DOE. What specific modeling variables are you targeting, and what is the estimated financial impact per MMBtu if these changes are approved?